FDA Inspection 1028577 — Ishihara Sangyo Kaisha, Ltd.
The FDA completed an inspection of Ishihara Sangyo Kaisha, Ltd. on September 8, 2017 in Yokkaichi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 8, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yokkaichi (Japan)